| 000 | 01601 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518092742.0 | ||
| 264 | 0 | _c20210528 | |
| 008 | 202105s 0 0 eng d | ||
| 022 | _a1745-7254 | ||
| 024 | 7 |
_a10.1038/s41401-020-0392-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSu, Zhen-Li | |
| 245 | 0 | 0 |
_aAloe-emodin exerts cholesterol-lowering effects by inhibiting proprotein convertase subtilisin/kexin type 9 in hyperlipidemic rats. _h[electronic resource] |
| 260 |
_bActa pharmacologica Sinica _cAug 2020 |
||
| 300 |
_a1085-1092 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnthraquinones _xtherapeutic use |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDiet, High-Fat |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperlipidemias _xdrug therapy |
| 650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Proteins _xmetabolism |
| 650 | 0 | 4 | _aPCSK9 Inhibitors |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptors, LDL _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSterol Regulatory Element Binding Proteins _xmetabolism |
| 700 | 1 | _aHang, Peng-Zhou | |
| 700 | 1 | _aHu, Juan | |
| 700 | 1 | _aZheng, Yu-Yang | |
| 700 | 1 | _aSun, Han-Qi | |
| 700 | 1 | _aGuo, Jing | |
| 700 | 1 | _aLiu, Ke-Yu | |
| 700 | 1 | _aDu, Zhi-Min | |
| 773 | 0 |
_tActa pharmacologica Sinica _gvol. 41 _gno. 8 _gp. 1085-1092 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41401-020-0392-8 _zAvailable from publisher's website |
| 999 |
_c30771541 _d30771541 |
||